Lobbying

Corporate Friends of CDC's latest lobbying report covers Q2 2026, at $20K. The four quarters Q4 2025–Q3 2026 total $60K. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Health Issues.

Corporate Friends of CDC

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$60K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Corporate Friends of CDC lobbying by quarter
Corporate Friends of CDC lobbying by quarter
QuarterAmountReports
Q4 2022$20K1
Q1 2023$20K1
Q2 2023$20K1
Q3 2023$20K1
Q4 2023$30K1
Q1 2024$30K1
Q2 2024$30K1
Q3 2024$30K1
Q4 2024$30K1
Q1 2025$20K1
Q2 2025$20K1
Q3 2025$20K1
Q4 2025$20K1
Q1 2026$20K1
Q2 2026$20K1
Q3 2026$00

By issue

  • Budget and appropriations$195K · 15 reports
  • Health issues$155K · 13 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Health & Human Services, Dept of (HHS)15 reports
  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports

Firms it paid

Firm
Troutman Strategies$350K15 quarters

Former officials lobbying for it

Former position
CHRISTOPHER BAXTERResearch Assistant, Senator Bob MenendezQ2 2026
LINDSAY JORDAN AUSTINLegislative Assistant, Rep. Lynn WestmorelandQ2 2026
RYAN DIFFLEYLegislative Assistant, Rep. Robert AderholtQ2 2026
TOM TILTONLegislative Assistant, Rep. Betty SuttonQ2 2026

Lobbying reports

Filed by
07/16for Q2Troutman Strategies$20K
04/19for Q1Troutman Strategies$20K
01/15for Q4 2025Troutman Strategies$20K
25/10/16for Q3 2025Troutman Strategies$20K
25/07/16for Q2 2025Troutman Strategies$20K
25/04/09for Q1 2025Troutman Strategies$20K
25/01/19for Q4 2024Troutman Strategies$30K
24/10/17for Q3 2024Troutman Strategies$30K
24/07/19for Q2 2024Troutman Strategies$30K
24/04/18for Q1 2024Troutman Strategies$30K
24/01/19for Q4 2023Troutman Strategies$30K
23/10/18for Q3 2023Troutman Strategies$20K
23/07/20for Q2 2023Troutman Strategies$20K
23/04/20for Q1 2023Troutman Strategies$20K
23/01/19for Q4 2022Troutman Strategies$20K